INTC vs URGN · rev $29.70B vs rev $123.4M
Intel Corporation (INTC) versus UroGen Pharma Ltd (URGN) — a side-by-side from cached financials, not a winner call.
Intel Corporation (INTC) is a semiconductors company listed on US. It is led by Lip-Bu Tan.
UroGen Pharma Ltd (URGN) is a biotechnology company listed on NASDAQ.
Latest reported INTC revenue for 2026-06-27 was $29.70B. Net income was -$14.76B. INTC currently screens at market cap $498.43B.
Latest reported URGN revenue for 2026-06-30 was $123.4M. Net income was -$37.9M. URGN currently screens at market cap $1.61B.
INTC currently screens at market cap $498.43B. URGN currently screens at market cap $1.61B.
Not investment advice. Open the INTC and URGN stock pages for the full models.
Not investment advice.